Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Dr. Jeremy G. ChadwickCOO | -13,13k | 1,06M | Automatic Disposition | 79,39 - 82,08 | 1,97k | -86,97% |
| 2026-05-26 | Dr. Jeremy G. ChadwickCOO | -4,05k | 317,92k | Verkauf | 78,36 - 79,17 | 1,97k | -67,32% |
| 2026-05-19 | Dr. Pamela EspositoIndependent Director | 1.000,00 | 31,20k | Derivative Exercise and Retained Stock | 31,20 | 1.000,00 | - |
| 2026-05-18 | Mr. Bruce N. JacobsCFO | 15,00k | 31,20k | Derivative Exercise and Retained Stock | 2,08 | 199,52k | 8,13% |
| 2026-05-11 | Ms. Elena H. RidloffIndependent Director | -3,00k | 167,40k | Derivative Exercise and Sale | 31,20 - 87,00 | 0,00 | - |
| 2026-04-29 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -30,00k | 2,37M | Derivative Exercise and Sale | 2,08 - 82,45 | 666,20k | - |
| 2026-04-22 | Atlas Venture Advisors, Inc.Unternehmen | -100,00 | 9,01k | Automatic Disposition | 90,08 | 4,57M | -0,00% |
| 2026-04-22 | Dr. Bruce L. BoothCo-Founder & Independent Chairman | -5,90k | 445,59k | Derivative Exercise and Sale | 14,18 - 89,96 | 0,00 | - |
| 2026-04-22 | Dr. Jeremy G. ChadwickCOO | -300,00 | 15,28k | Derivative Exercise and Sale | 30,17 - 90,00 | 15,01k | - |
| 2026-04-14 | Mr. Noah GoodmanChief Business Officer | -1,35k | 121,23k | Automatic Disposition | 90,00 | 50,20k | -2,61% |
| 2026-04-14 | Dr. Jeremy G. ChadwickCOO | -6,55k | 364,16k | Derivative Exercise and Sale | 30,17 - 90,00 | 15,01k | - |
| 2026-04-15 | Atlas Venture Advisors, Inc.Unternehmen | -3,14k | 282,46k | Automatic Disposition | 90,10 | 4,57M | -0,07% |
| 2026-04-14 | Dr. Bruce L. BoothCo-Founder & Independent Chairman | -6,36k | 481,90k | Derivative Exercise and Sale | 14,18 - 89,97 | 0,00 | - |
| 2026-04-09 | Mr. Noah GoodmanChief Business Officer | -2,50k | 163,92k | Derivative Exercise and Sale | 21,05 - 86,62 | 4,82k | - |
| 2026-04-09 | Mr. Noah GoodmanChief Business Officer | -3,26k | 284,04k | Verkauf | 86,62 - 87,11 | 4,82k | -40,39% |
| 2026-04-09 | Mr. Noah GoodmanChief Business Officer | -4,50k | 397,20k | Automatic Disposition | 87,35 - 89,00 | 4,82k | -48,30% |
| 2026-03-31 | Ms. Elena H. RidloffIndependent Director | -12,00k | 854,50k | Derivative Exercise and Sale | 14,18 - 86,05 | 0,00 | - |
| 2026-03-31 | Dr. Jeremy G. ChadwickCOO | -22,24k | 1,24M | Derivative Exercise and Sale | 29,64 - 86,05 | 19,15k | - |
| 2026-03-23 | Dr. Jeremy G. ChadwickCOO | -109,13k | 5,27M | Derivative Exercise and Sale | 29,64 - 80,26 | 19,15k | - |
| 2026-03-23 | Dr. Jeremy G. ChadwickCOO | -6,85k | 547,33k | Automatic Disposition | 79,87 - 80,05 | 19,15k | -26,34% |
| 2026-03-20 | Dr. Pamela EspositoIndependent Director | -2,50k | 75,13k | Derivative Exercise and Sale | 49,10 - 79,94 | 0,00 | - |
| 2026-03-11 | Dr. Jeremy G. ChadwickCOO | -20,00k | 793,62k | Derivative Exercise and Sale | 43,50 - 83,72 | 17,67k | - |
| 2026-03-11 | Dr. Jeremy G. ChadwickCOO | -5,76k | 482,06k | Automatic Disposition | 83,72 | 17,67k | -24,58% |
| 2026-03-02 | Mr. Bruce N. JacobsCFO | -12,47k | 1,09M | Verkauf | 84,00 - 89,66 | 174,52k | -6,67% |
| 2026-03-02 | Dr. Jared A. GollobChief Medical Officer | -10,51k | 916,67k | Verkauf | 84,00 - 89,66 | 71,36k | -12,84% |
| 2026-03-02 | Dr. Jeremy G. ChadwickCOO | -5,96k | 515,59k | Verkauf | 84,00 - 89,66 | 23,43k | -20,28% |
| 2026-03-02 | Atlas Venture Advisors, Inc.Unternehmen | -81,87k | 7,38M | Automatic Disposition | 90,13 | 4,58M | -1,76% |
| 2026-02-25 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -30,00k | 2,65M | Derivative Exercise and Sale | 2,08 - 93,49 | 666,20k | - |
| 2026-02-20 | Dr. Pamela EspositoIndependent Director | -2,50k | 95,52k | Derivative Exercise and Sale | 49,10 - 88,10 | 0,00 | - |
| 2026-01-20 | Dr. Pamela EspositoIndependent Director | -5,50k | 157,17k | Derivative Exercise and Sale | 31,20 - 68,52 | - | - |
| 2026-01-05 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | 3,12k | 99,99k | Derivative Exercise and Retained Stock | 32,07 | 666,20k | 0,47% |
| 2025-12-31 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -30,00k | 2,28M | Derivative Exercise and Sale | 2,08 - 78,52 | 663,08k | - |
| 2025-12-17 | Dr. Pamela EspositoIndependent Director | -27,56k | 1,22M | Derivative Exercise and Sale | 27,67 - 84,07 | 0,00 | - |
| 2025-12-17 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | 2,60k | 99,99k | Derivative Exercise and Retained Stock | 38,53 | 663,08k | 0,39% |
| 2025-12-10 | Atlas Venture Advisors, Inc.Unternehmen | -236,59k | 21,70M | Verkauf | 88,64 - 93,20 | 4,66M | -4,83% |
| 2025-12-11 | Baker Bros. Advisors LPUnternehmen | 2,01M | 172,50M | Kauf | 86,00 | 8,66M | 30,16% |
| 2025-12-08 | Mr. Jeffrey W. AlbersIndependent Director | -5,00k | 377,92k | Derivative Exercise and Sale | 14,18 - 90,30 | - | - |
| 2025-12-08 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -100,00k | 8,71M | Derivative Exercise and Sale | 2,08 - 89,17 | 660,48k | - |
| 2025-12-08 | Dr. Jared A. GollobChief Medical Officer | -49,31k | 4,11M | Derivative Exercise and Sale | 5,33 - 92,19 | 57,49k | - |
| 2025-10-29 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -30,00k | 1,77M | Derivative Exercise and Sale | 2,08 - 61,46 | 660,48k | - |
| 2025-10-15 | Dr. Jared A. GollobChief Medical Officer | -51,21k | 3,05M | Derivative Exercise and Sale | 1,31 - 62,72 | 57,49k | - |
| 2025-10-15 | Dr. Jared A. GollobChief Medical Officer | -8,37k | 527,15k | Automatic Disposition | 62,72 - 63,09 | 57,49k | -12,70% |
| 2025-10-13 | Dr. Jared A. GollobChief Medical Officer | -1,47k | 85,93k | Derivative Exercise and Sale | 1,31 - 60,00 | 65,86k | - |
| 2025-10-13 | Dr. Jared A. GollobChief Medical Officer | -1,64k | 98,46k | Automatic Disposition | 60,00 | 65,86k | -2,43% |
| 2025-10-13 | Mr. Jeffrey W. AlbersIndependent Director | -5,00k | 244,25k | Derivative Exercise and Sale | 10,34 - 59,19 | 0,00 | - |
| 2025-09-17 | Mr. Bruce N. JacobsCFO | -79,22k | 3,80M | Derivative Exercise and Sale | 2,08 - 50,00 | 168,66k | - |
| 2025-09-16 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -30,00k | 1,41M | Derivative Exercise and Sale | 2,08 - 49,00 | 660,48k | - |
| 2025-06-30 | BVF Partners L.P.Unternehmen | 317,17k | 13,96M | Kauf | 44,00 | 5,48M | 6,14% |
| 2025-06-30 | Baker Bros. Advisors LPUnternehmen | 655,50k | 0,00 | Open Market Derivative Acquisition | 0,00 | 10,23M | 6,85% |
| 2025-06-30 | Baker Bros. Advisors LPUnternehmen | 655,50k | 28,84M | Kauf | 44,00 | 6,65M | 10,93% |
| 2025-06-11 | Ms. Elena H. RidloffIndependent Director | -4,50k | 133,70k | Derivative Exercise and Sale | 20,29 - 50,00 | 0,00 | - |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
